Literature DB >> 15025565

The vaccinia virus-stimulated mitogen-activated protein kinase (MAPK) pathway is required for virus multiplication.

Anderson A Andrade1, Patrícia N G Silva, Anna C T C Pereira, Lirlândia P De Sousa, Paulo C P Ferreira, Ricardo T Gazzinelli, Erna G Kroon, Catherine Ropert, Cláudio A Bonjardim.   

Abstract

Early events play a decisive role in virus multiplication. We have shown previously that activation of MAPK/ERK1/2 (mitogen-activated protein kinase/extracellular-signal-regulated kinase 1/2) and protein kinase A are pivotal for vaccinia virus (VV) multiplication [de Magalhães, Andrade, Silva, Sousa, Ropert, Ferreira, Kroon, Gazzinelli and Bonjardim (2001) J. Biol. Chem. 276, 38353-38360]. In the present study, we show that VV infection provoked a sustained activation of both ERK1/2 and RSK2 (ribosomal S6 kinase 2). Our results also provide evidence that this pattern of kinase activation depends on virus multiplication and ongoing protein synthesis and is maintained independently of virus DNA synthesis. It is noteworthy that the VGF (VV growth factor), although involved, is not essential for prolonged ERK1/2 activation. Furthermore, our findings suggest that the VV-stimulated ERK1/2 activation also seems to require actin dynamics, microtubule polymerization and tyrosine kinase phosphorylation. The VV-stimulated pathway MEK/ERK1/2/RSK2 (where MEK stands for MAPK/ERK kinase) leads to phosphorylation of the ternary complex factor Elk-1 and expression of the early growth response (egr-1) gene, which kinetically paralleled the kinase activation. The recruitment of this pathway is biologically relevant, since its disruption caused a profound effect on viral thymidine kinase gene expression, viral DNA replication and VV multiplication. This pattern of sustained kinase activation after VV infection is unique. In addition, by connecting upstream signals generated at the cytoskeleton and by tyrosine kinase, the MEK/ERK1/2/RSK2 cascade seems to play a decisive role not only at early stages of the infection, i.e. post-penetration, but is also crucial to define the fate of virus progeny.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15025565      PMCID: PMC1133850          DOI: 10.1042/BJ20031375

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  50 in total

1.  Entry of the two infectious forms of vaccinia virus at the plasma membane is signaling-dependent for the IMV but not the EEV.

Authors:  J K Locker; A Kuehn; S Schleich; G Rutter; H Hohenberg; R Wepf; G Griffiths
Journal:  Mol Biol Cell       Date:  2000-07       Impact factor: 4.138

2.  A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling.

Authors:  A Bowie; E Kiss-Toth; J A Symons; G L Smith; S K Dower; L A O'Neill
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

3.  The purification fo four strains of poxvirus.

Authors:  W K JOKLIK
Journal:  Virology       Date:  1962-09       Impact factor: 3.616

4.  Influenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling cascade.

Authors:  S Pleschka; T Wolff; C Ehrhardt; G Hobom; O Planz; U R Rapp; S Ludwig
Journal:  Nat Cell Biol       Date:  2001-03       Impact factor: 28.824

5.  Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms.

Authors:  A Bonni; A Brunet; A E West; S R Datta; M A Takasu; M E Greenberg
Journal:  Science       Date:  1999-11-12       Impact factor: 47.728

6.  Actin-based motility of vaccinia virus mimics receptor tyrosine kinase signalling.

Authors:  F Frischknecht; V Moreau; S Röttger; S Gonfloni; I Reckmann; G Superti-Furga; M Way
Journal:  Nature       Date:  1999-10-28       Impact factor: 49.962

7.  Sustained activation of the Raf/MEK/Erk pathway in response to EGF in stable cell lines expressing the Hepatitis C Virus (HCV) core protein.

Authors:  S Giambartolomei; F Covone; M Levrero; C Balsano
Journal:  Oncogene       Date:  2001-05-03       Impact factor: 9.867

8.  Regulation of bad phosphorylation and association with Bcl-x(L) by the MAPK/Erk kinase.

Authors:  M P Scheid; K M Schubert; V Duronio
Journal:  J Biol Chem       Date:  1999-10-22       Impact factor: 5.157

9.  Differential usage of signal transduction pathways defines two types of serum response factor target gene.

Authors:  D Gineitis; R Treisman
Journal:  J Biol Chem       Date:  2001-05-07       Impact factor: 5.157

10.  Vaccinia virus infection disrupts microtubule organization and centrosome function.

Authors:  A Ploubidou; V Moreau; K Ashman; I Reckmann; C González; M Way
Journal:  EMBO J       Date:  2000-08-01       Impact factor: 11.598

View more
  72 in total

1.  Equine herpesvirus 1 enters cells by two different pathways, and infection requires the activation of the cellular kinase ROCK1.

Authors:  Arthur R Frampton; Donna B Stolz; Hiroaki Uchida; William F Goins; Justus B Cohen; Joseph C Glorioso
Journal:  J Virol       Date:  2007-08-01       Impact factor: 5.103

2.  Vaccinia virus activation of CCR5 invokes tyrosine phosphorylation signaling events that support virus replication.

Authors:  Ramtin Rahbar; Thomas T Murooka; Anna A Hinek; Carole L Galligan; Antonella Sassano; Celeste Yu; Kishore Srivastava; Leonidas C Platanias; Eleanor N Fish
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

3.  Host response to the attenuated poxvirus vector NYVAC: upregulation of apoptotic genes and NF-kappaB-responsive genes in infected HeLa cells.

Authors:  Susana Guerra; Luis A López-Fernández; Alberto Pascual-Montano; José Luis Nájera; Angel Zaballos; Mariano Esteban
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

4.  Role of cell signaling in poxvirus-mediated foreign gene expression in mammalian cells.

Authors:  Ningjie Hu; Richard Yu; Cecilia Shikuma; Bruce Shiramizu; Mario A Ostrwoski; Qigui Yu
Journal:  Vaccine       Date:  2009-03-10       Impact factor: 3.641

5.  Mechanism of sustained activation of ribosomal S6 kinase (RSK) and ERK by kaposi sarcoma-associated herpesvirus ORF45: multiprotein complexes retain active phosphorylated ERK AND RSK and protect them from dephosphorylation.

Authors:  Ersheng Kuang; Fayi Wu; Fanxiu Zhu
Journal:  J Biol Chem       Date:  2009-03-20       Impact factor: 5.157

6.  A novel cellular protein, VPEF, facilitates vaccinia virus penetration into HeLa cells through fluid phase endocytosis.

Authors:  Cheng-Yen Huang; Tsai-Yi Lu; Chi-Horng Bair; Yuan-Shau Chang; Jeng-Kuan Jwo; Wen Chang
Journal:  J Virol       Date:  2008-06-11       Impact factor: 5.103

7.  Vesicular stomatitis virus matrix protein impairs CD1d-mediated antigen presentation through activation of the p38 MAPK pathway.

Authors:  Gourapura J Renukaradhya; Masood A Khan; Daniel Shaji; Randy R Brutkiewicz
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

8.  Yersinia virulence factor YopM induces sustained RSK activation by interfering with dephosphorylation.

Authors:  Moritz Hentschke; Laura Berneking; Cristina Belmar Campos; Friedrich Buck; Klaus Ruckdeschel; Martin Aepfelbacher
Journal:  PLoS One       Date:  2010-10-05       Impact factor: 3.240

9.  Vaccinia virus-encoded ribonucleotide reductase subunits are differentially required for replication and pathogenesis.

Authors:  Don B Gammon; Branawan Gowrishankar; Sophie Duraffour; Graciela Andrei; Chris Upton; David H Evans
Journal:  PLoS Pathog       Date:  2010-07-08       Impact factor: 6.823

10.  Increased ATP generation in the host cell is required for efficient vaccinia virus production.

Authors:  Chia-Wei Chang; Hui-Chun Li; Che-Fang Hsu; Chiao-Yen Chang; Shih-Yen Lo
Journal:  J Biomed Sci       Date:  2009-09-02       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.